Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers

Dennis Thomas, Michael J Abramson, Billie Bonevski, Simone Taylor, Susan G Poole, Gregory Weeks, Michael J Dooley, Johnson George

Research output: Contribution to journalArticleResearchpeer-review

11 Citations (Scopus)

Abstract

Objective: Understanding smokers' quit experiences and their preferences for a future quit attempt may aid in the development of effective cessation treatments. The aims of this study were to measure tobacco use behaviour; previous quit attempts and outcomes; methods used to assist quitting; difficulties experienced during previous attempts; the motives and preferred methods to assist quitting in a future attempt; identify the factors associated with preferences for smoking cessation. Design: Face-to-face interview using a structured questionnaire. Setting: Inpatient wards of three Australian public hospitals. Participants: Hospitalised smokers enrolled in a smoking cessation trial. Results: Of 600 enrolled patients (42.8% participation rate), 64.3% (n=386) had attempted quitting in the previous 12 months. On a scale of 1 (low) to 10 (high), current motivation to quit smoking was high (median 9; IQR 6.5-10), but confidence was modest (median 5; IQR 3-8). Among 386 participants who reported past quit attempts, 69.9% (n=270) had used at least one cessation aid to assist quitting. Nicotine replacement therapy (NRT) was most commonly stated (222, 57.5%), although the majority had used NRT for <4 weeks. Hypnotherapy was the most common (68, 17.6%) non-pharmacological treatment. Over 80% (n=311) experienced withdrawal symptoms; craving and irritability were commonly reported. Most participants (351, 58.5%) believed medications, especially NRT (322, 53.7%), would assist them to quit in the future. History of previous smoking cessation medication use was the only independent predictor of interest in using medications for a future quit attempt. Conclusions: The majority of smokers had attempted quitting in the previous 12 months; NRT was a popular cessation treatment, although it was not used as recommended by most. This suggests a need for assistance in the selection and optimal use of cessation aids for hospitalised smokers. Trial registration number: Australian and New Zealand Clinical Trials Registry: ACTRN12612000368831.
Original languageEnglish
Article numbere006959
Number of pages9
JournalBMJ Open
Volume5
Issue number4
DOIs
Publication statusPublished - 2015

Cite this

Thomas, Dennis ; Abramson, Michael J ; Bonevski, Billie ; Taylor, Simone ; Poole, Susan G ; Weeks, Gregory ; Dooley, Michael J ; George, Johnson. / Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers. In: BMJ Open. 2015 ; Vol. 5, No. 4.
@article{7bc1460cc1974371a120ac2d75091287,
title = "Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers",
abstract = "Objective: Understanding smokers' quit experiences and their preferences for a future quit attempt may aid in the development of effective cessation treatments. The aims of this study were to measure tobacco use behaviour; previous quit attempts and outcomes; methods used to assist quitting; difficulties experienced during previous attempts; the motives and preferred methods to assist quitting in a future attempt; identify the factors associated with preferences for smoking cessation. Design: Face-to-face interview using a structured questionnaire. Setting: Inpatient wards of three Australian public hospitals. Participants: Hospitalised smokers enrolled in a smoking cessation trial. Results: Of 600 enrolled patients (42.8{\%} participation rate), 64.3{\%} (n=386) had attempted quitting in the previous 12 months. On a scale of 1 (low) to 10 (high), current motivation to quit smoking was high (median 9; IQR 6.5-10), but confidence was modest (median 5; IQR 3-8). Among 386 participants who reported past quit attempts, 69.9{\%} (n=270) had used at least one cessation aid to assist quitting. Nicotine replacement therapy (NRT) was most commonly stated (222, 57.5{\%}), although the majority had used NRT for <4 weeks. Hypnotherapy was the most common (68, 17.6{\%}) non-pharmacological treatment. Over 80{\%} (n=311) experienced withdrawal symptoms; craving and irritability were commonly reported. Most participants (351, 58.5{\%}) believed medications, especially NRT (322, 53.7{\%}), would assist them to quit in the future. History of previous smoking cessation medication use was the only independent predictor of interest in using medications for a future quit attempt. Conclusions: The majority of smokers had attempted quitting in the previous 12 months; NRT was a popular cessation treatment, although it was not used as recommended by most. This suggests a need for assistance in the selection and optimal use of cessation aids for hospitalised smokers. Trial registration number: Australian and New Zealand Clinical Trials Registry: ACTRN12612000368831.",
author = "Dennis Thomas and Abramson, {Michael J} and Billie Bonevski and Simone Taylor and Poole, {Susan G} and Gregory Weeks and Dooley, {Michael J} and Johnson George",
year = "2015",
doi = "10.1136/bmjopen-2014-006959",
language = "English",
volume = "5",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",
number = "4",

}

Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers. / Thomas, Dennis; Abramson, Michael J; Bonevski, Billie; Taylor, Simone; Poole, Susan G; Weeks, Gregory; Dooley, Michael J; George, Johnson.

In: BMJ Open, Vol. 5, No. 4, e006959, 2015.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers

AU - Thomas, Dennis

AU - Abramson, Michael J

AU - Bonevski, Billie

AU - Taylor, Simone

AU - Poole, Susan G

AU - Weeks, Gregory

AU - Dooley, Michael J

AU - George, Johnson

PY - 2015

Y1 - 2015

N2 - Objective: Understanding smokers' quit experiences and their preferences for a future quit attempt may aid in the development of effective cessation treatments. The aims of this study were to measure tobacco use behaviour; previous quit attempts and outcomes; methods used to assist quitting; difficulties experienced during previous attempts; the motives and preferred methods to assist quitting in a future attempt; identify the factors associated with preferences for smoking cessation. Design: Face-to-face interview using a structured questionnaire. Setting: Inpatient wards of three Australian public hospitals. Participants: Hospitalised smokers enrolled in a smoking cessation trial. Results: Of 600 enrolled patients (42.8% participation rate), 64.3% (n=386) had attempted quitting in the previous 12 months. On a scale of 1 (low) to 10 (high), current motivation to quit smoking was high (median 9; IQR 6.5-10), but confidence was modest (median 5; IQR 3-8). Among 386 participants who reported past quit attempts, 69.9% (n=270) had used at least one cessation aid to assist quitting. Nicotine replacement therapy (NRT) was most commonly stated (222, 57.5%), although the majority had used NRT for <4 weeks. Hypnotherapy was the most common (68, 17.6%) non-pharmacological treatment. Over 80% (n=311) experienced withdrawal symptoms; craving and irritability were commonly reported. Most participants (351, 58.5%) believed medications, especially NRT (322, 53.7%), would assist them to quit in the future. History of previous smoking cessation medication use was the only independent predictor of interest in using medications for a future quit attempt. Conclusions: The majority of smokers had attempted quitting in the previous 12 months; NRT was a popular cessation treatment, although it was not used as recommended by most. This suggests a need for assistance in the selection and optimal use of cessation aids for hospitalised smokers. Trial registration number: Australian and New Zealand Clinical Trials Registry: ACTRN12612000368831.

AB - Objective: Understanding smokers' quit experiences and their preferences for a future quit attempt may aid in the development of effective cessation treatments. The aims of this study were to measure tobacco use behaviour; previous quit attempts and outcomes; methods used to assist quitting; difficulties experienced during previous attempts; the motives and preferred methods to assist quitting in a future attempt; identify the factors associated with preferences for smoking cessation. Design: Face-to-face interview using a structured questionnaire. Setting: Inpatient wards of three Australian public hospitals. Participants: Hospitalised smokers enrolled in a smoking cessation trial. Results: Of 600 enrolled patients (42.8% participation rate), 64.3% (n=386) had attempted quitting in the previous 12 months. On a scale of 1 (low) to 10 (high), current motivation to quit smoking was high (median 9; IQR 6.5-10), but confidence was modest (median 5; IQR 3-8). Among 386 participants who reported past quit attempts, 69.9% (n=270) had used at least one cessation aid to assist quitting. Nicotine replacement therapy (NRT) was most commonly stated (222, 57.5%), although the majority had used NRT for <4 weeks. Hypnotherapy was the most common (68, 17.6%) non-pharmacological treatment. Over 80% (n=311) experienced withdrawal symptoms; craving and irritability were commonly reported. Most participants (351, 58.5%) believed medications, especially NRT (322, 53.7%), would assist them to quit in the future. History of previous smoking cessation medication use was the only independent predictor of interest in using medications for a future quit attempt. Conclusions: The majority of smokers had attempted quitting in the previous 12 months; NRT was a popular cessation treatment, although it was not used as recommended by most. This suggests a need for assistance in the selection and optimal use of cessation aids for hospitalised smokers. Trial registration number: Australian and New Zealand Clinical Trials Registry: ACTRN12612000368831.

UR - http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401863/pdf/bmjopen-2014-006959.pdf

U2 - 10.1136/bmjopen-2014-006959

DO - 10.1136/bmjopen-2014-006959

M3 - Article

VL - 5

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 4

M1 - e006959

ER -